THE ASSOCIATION OF CHADS-P2A2RC RISK SCORE WITH OUTCOMES IN PATIENTS TAKING P2Y12 INHIBITOR MONOTHERAPY AFTER 3 MONTHS OF DUAL ANTIPLATELET THERAPY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION

被引:0
|
作者
Song, P. -S. [1 ]
Jeong, J. -O. [1 ]
机构
[1] Chungnam Natl Univ Hosp, Cardiol, Daejeon, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P536
引用
收藏
页码:S174 / S174
页数:1
相关论文
共 50 条
  • [1] The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
    Song, Pil Sang
    Seong, Seok-Woo
    Kim, Ji-Yeon
    An, Soo Yeon
    Kim, Mi Joo
    Ahn, Kye Taek
    Jin, Seon-Ah
    Jeong, Jin-Ok
    Yang, Jeong Hoon
    Hahn, Joo-Yong
    Gwon, Hyeon-Cheol
    Jang, Woo Jin
    Yoon, Hyuck Jun
    Bae, Jang-Whan
    Choi, Woong Gil
    Bin Song, Young
    KOREAN CIRCULATION JOURNAL, 2024, 54 (04) : 189 - 200
  • [2] The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention
    Kim, Ji-Yeon
    Jeong, Jin-Ok
    Song, Pil Sang
    Song, Young Bin
    Hahn, Joo-Yong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B15 - B15
  • [3] P2Y12 INHIBITOR MONOTHERAPY OR DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH HYPERTENSION
    Pil-Sang, Song
    Jin-Ok, Jeong
    JOURNAL OF HYPERTENSION, 2023, 41 : E178 - E178
  • [4] P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    McCaw, Zachary R.
    Wei, Lee-Jen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (16): : 1607 - 1607
  • [5] P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Ando, Giuseppe
    De Santis, Giulia Azzurra
    Greco, Antonio
    Pistelli, Lorenzo
    Francaviglia, Bruno
    Capodanno, Davide
    De Caterina, Raffaele
    Capranzano, Piera
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (22) : 2239 - 2249
  • [6] Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Shin, Eun-Seok
    Her, Ae-Young
    Kim, Bitna
    Hahn, Joo-Yong
    Bin Song, Young
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Lee, Sang Hoon
    Gwon, Hyeon-Cheol
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (45)
  • [7] P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
    Gragnano, Felice
    Mehran, Roxana
    Branca, Mattia
    Franzone, Anna
    Baber, Usman
    Jang, Yangsoo
    Kimura, Takeshi
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Kim, Byeong-Keuk
    Watanabe, Hirotoshi
    Bin Song, Young
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Hong, Sung-Jin
    Ando, Kenji
    Gwon, Hyeon-Cheol
    Calabro, Paolo
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (06) : 537 - 552
  • [8] P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
    Zhou, Xuan
    Angiolillo, Dominick J.
    Ortega-Paz, Luis
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (10)
  • [9] P2Y12 Inhibitor Monotherapy After Short-term Dual Antiplatelet Therapy in Patients Receiving Percutaneous Coronary Intervention
    Lone, Ahmad Naeem
    Khan, Safi U.
    CIRCULATION, 2020, 142
  • [10] P2Y12 Inhibitor vs Aspirin Monotherapy Following Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: An Updated Meta-Analysis
    Gao, Tong
    Meng, Chang
    Wang, Yintang
    Li, Siyuan
    Bi, Lei
    Geng, Yu
    Zhang, Ping
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (10)